Literature DB >> 10642768

Fatal cerebral hemorrhage and severe thrombocytopenia during abciximab treatment.

B Vahdat1, I Canavy, L Fourcade, E Garcia, J Quilici, J L Bonnet, M Bory.   

Abstract

We describe the case of a fatal cerebral hemorrhage associated with a severe thrombocytopenia (4.0 x 10(9)/l), occurring only 90 min after starting treatment with abciximab, in a patient undergoing primary percutaneous transluminal coronary angioplasty (PTCA) for an acute myocardial infarction. Cathet. Cardiovasc. Intervent. 49:177-180, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10642768     DOI： 10.1002/(sici)1522-726x(200002)49:2<177::aid-ccd13>3.0.co;2-j

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN： 1522-1946            Impact factor:   2.692


  7 in total

Review 1.  Glycoprotein IIb/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment.

Authors:  S M Said; J Hahn; E Schleyer; M Müller; G M Fiedler; M Buerke; R Prondzinsky
Journal:  Clin Res Cardiol       Date:  2006-12-08       Impact factor: 5.460

2.  Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study.

Authors:  Edeltraut Garbe; Frank Andersohn; Elisabeth Bronder; Abdulgabar Salama; Andreas Klimpel; Michael Thomae; Hubert Schrezenmeier; Martin Hildebrandt; Ernst Späth-Schwalbe; Andreas Grüneisen; Oliver Meyer; Hanife Kurtal
Journal:  Eur J Clin Pharmacol       Date:  2011-12-21       Impact factor: 2.953

Review 3.  Hemorrhagic transformation following ischemic stroke: significance, causes, and relationship to therapy and treatment.

Authors:  Paul A Lapchak
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

4.  Intracranial hemorrhage following neuroendovascular procedures with abciximab is associated with high mortality: a multicenter series.

Authors:  Ryan D Walsh; Kevin M Barrett; Maria I Aguilar; Giuseppe Lanzino; Ricardo A Hanel; David A Miller; Brian W Chong; W David Freeman
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

5.  Deaths associated with platelet glycoprotein IIb/IIIa inhibitor treatment.

Authors:  D L Brown
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

Review 6.  Causality assessment between reported fatal cerebral haemorrhage and suspected drugs: developing a new algorithm based on the analysis of the Japanese Adverse Event Report (JADER) database and literature review.

Authors:  Miki Ohta
Journal:  Eur J Clin Pharmacol       Date:  2021-04-07       Impact factor: 2.953

7.  Profound thrombocytopenia after primary exposure to eptifibatide.

Authors:  Nicholas B Norgard; Brian T Badgley
Journal:  Drug Healthc Patient Saf       Date:  2010-09-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.